PLIANT THERAPEUTICS, INC. - 10-Q Filing
Pliant Therapeutics reports third quarter 2026 financial results including updated fair value measurements and equity incentive plan details.
Tickers: $PLRX
Pliant Therapeutics reports third quarter 2026 financial results including updated fair value measurements and equity incentive plan details.
Tickers: $PLRX